1. Balch, C.M., Soong, S.-j., Shaw, H.M.et al. (1992) An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In C. M. Balch, A. N. Houghton, G. W. Milton, A. j. Sober and S.-j. Soong (eds)Cutaneous melanoma, pp 165–87. Philadelphia: J.B. Lippincott.
2. Houghton, A.N., Legha, S. and Bajorin, D.F. (1992) Chemotherapy for metastatic melanoma. In C. M. Balch, A. N. Houghton, G. W. Milton, A. J. Sober and S.-j. Soong (eds)Cutaneous melanoma, pp 498–508. Philadelphia: J.B. Lippincott.
3. Karlsson, M., Jungnelius, U., Aamdal, S.et al. (1996) Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma.Int. J. Cancer 65, 1–5.
4. Kleberg, U.R., Engel, E., Israels, P.etal (1995) Palliative therapy of melanoma patients with fotemustine. Inverse relationship between tumour load and treatment effectiveness. A multicentre phase II trial of the EORTC-Melanoma Cooperative Group (MCG).Melanoma Res 5, 195–200.
5. Joensuu, H. (1991) Association between chemotherapy response and rate of disease progression in disseminated melanoma.Br. J. Cancer 63, 154–6.